Clinical Trial Update: Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the safety and efficacy of T10430 eye drops to control pediatric myopia progression. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• T10430 Eye Drops

Snippet

Sponsor: Laboratoires Thea | Conditions: Myopia | Phase 2 | Status: RECRUITING